Bio-Rad Laboratories (BIO-B) Total Current Liabilities (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Total Current Liabilities data on file, last reported at $917.0 million in Q1 2026.

• Total Current Liabilities for Q1 2026 came in at $917.0 million, up 81.01% year-over-year; the trailing twelve-month figure through Mar 2026 was $917.0 million (up 81.01% YoY), and the FY2025 annual result was $517.0 million, up 10.52% from the prior year.
• Total Current Liabilities climbed to $917.0 million in Q1 2026 per BIO-B's latest filing, from $517.0 million in the prior quarter.
• Over five years, Total Current Liabilities peaked at $917.0 million in Q1 2026 and troughed at $466.2 million in Q1 2024.
• A 5-year average of $563.8 million and a median of $548.9 million in 2025 frame the typical range for Total Current Liabilities.
• The sharpest annual moves came in 2024 and 2026: Total Current Liabilities retreated 20.94% in 2024, then jumped 81.01% in 2026.
• A 5-year view of Total Current Liabilities shows it stood at $568.7 million in 2022, then fell by 8.07% to $522.8 million in 2023, then declined by 10.52% to $467.8 million in 2024, then rose by 10.52% to $517.0 million in 2025, then jumped by 77.37% to $917.0 million in 2026.
• Business Quant data shows BIO-B's Total Current Liabilities at $917.0 million in Q1 2026, $517.0 million in Q4 2025, and $522.3 million in Q3 2025.